301 related articles for article (PubMed ID: 17999080)
41. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
[TBL] [Abstract][Full Text] [Related]
42. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
43. Onchocerciasis control: biological research is still needed.
Boussinesq M
Parasite; 2008 Sep; 15(3):510-4. PubMed ID: 18814732
[TBL] [Abstract][Full Text] [Related]
44. Anti-
Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
[TBL] [Abstract][Full Text] [Related]
45. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
46. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.
Basáñez MG; Pion SD; Boakes E; Filipe JA; Churcher TS; Boussinesq M
Lancet Infect Dis; 2008 May; 8(5):310-22. PubMed ID: 18471776
[TBL] [Abstract][Full Text] [Related]
47. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
48. Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline.
Debrah AY; Mand S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Lawson B; Taylor M; Adjei O; Hoerauf A
Am J Trop Med Hyg; 2009 Jun; 80(6):956-63. PubMed ID: 19478258
[TBL] [Abstract][Full Text] [Related]
49. [Onchocerciasis].
Stingl P
MMW Fortschr Med; 2004 Nov; 146(45):44-5. PubMed ID: 15581105
[TBL] [Abstract][Full Text] [Related]
50. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT; Lazdins-Helds JK; Ahmed K; Boatin BA; Boakye DA; Edwards G
Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
[TBL] [Abstract][Full Text] [Related]
51. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria.
Brattig NW; Büttner DW; Hoerauf A
Microbes Infect; 2001 May; 3(6):439-46. PubMed ID: 11377205
[TBL] [Abstract][Full Text] [Related]
52. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
53. Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa.
Büttner DW; Wanji S; Bazzocchi C; Bain O; Fischer P
Filaria J; 2003 May; 2(1):10. PubMed ID: 12801420
[TBL] [Abstract][Full Text] [Related]
54. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
56. Imported onchocerciasis in migrants and travelers.
Showler AJ; Nutman TB
Curr Opin Infect Dis; 2018 Oct; 31(5):393-398. PubMed ID: 30113326
[TBL] [Abstract][Full Text] [Related]
57. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
58. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.
Tamarozzi F; Halliday A; Gentil K; Hoerauf A; Pearlman E; Taylor MJ
Clin Microbiol Rev; 2011 Jul; 24(3):459-68. PubMed ID: 21734243
[TBL] [Abstract][Full Text] [Related]
59. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients.
Eng JK; Prichard RK
Mol Biochem Parasitol; 2005 Aug; 142(2):193-202. PubMed ID: 15885823
[TBL] [Abstract][Full Text] [Related]
60. Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa.
Ardelli BF; Prichard RK
Ann Trop Med Parasitol; 2004 Jun; 98(4):371-84. PubMed ID: 15228718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
